STORONI; Laura
Patent Applications and Registrations
Patent applications and USPTO patent grants for STORONI; Laura.The latest application filed is for "nitric oxide releasing phosphodiesterase type 5 inhibitor".
- STORONI; Laura - CESANO MADERNO MB
- Storoni; Laura - Cesano Maderno IT
- Storoni; Laura - Milano IT
- Storoni; Laura - Cesano Maderno Milano
| Patent | Date |
|---|---|
| Nitric Oxide Releasing Phosphodiesterase Type 5 Inhibitor App 20210322413 - ALMIRANTE; Nicoletta ; et al. | 2021-10-21 |
| Combinations of prostaglandins and nitric oxide donors Grant 10,610,509 - Almirante , et al. | 2020-04-07 |
| Nitric oxide donating derivatives of fluprostenol Grant 10,280,138 - Almirante , et al. | 2019-05-07 |
| Nitric oxide donating carnosine compounds Grant 10,093,696 - Almirante , et al. October 9, 2 | 2018-10-09 |
| Nitric oxide donating derivatives of latanoprost free acid Grant 10,047,047 - Almirante , et al. August 14, 2 | 2018-08-14 |
| Nitric Oxide Donating Derivatives Of Latanoprost Free Acid App 20180118676 - ALMIRANTE; Nicoletta ; et al. | 2018-05-03 |
| Nitric Oxide Donating Derivatives Of Fluprostenol App 20180118677 - ALMIRANTE; Nicoletta ; et al. | 2018-05-03 |
| Ophthalmic compositions containing a nitric oxide donor Grant 9,895,335 - Ongini , et al. February 20, 2 | 2018-02-20 |
| Combinations Of Prostaglandins And Nitric Oxide Donors App 20170354634 - ALMIRANTE; Nicoletta ; et al. | 2017-12-14 |
| Nitric Oxide Donating Carnosine Compounds App 20170291920 - ALMIRANTE; Nicoletta ; et al. | 2017-10-12 |
| Quinone based nitric oxide donating compounds for ophthalmic use Grant 9,598,349 - Almirante , et al. March 21, 2 | 2017-03-21 |
| Quinone based nitric oxide donating compounds for ophthalmic use Grant 9,446,015 - Ongini , et al. September 20, 2 | 2016-09-20 |
| Ophthalmic Compositions Containing A Nitric Oxide Donor App 20160158182 - ONGINI; Ennio ; et al. | 2016-06-09 |
| Quinone Based Nitric Oxide Donating Compounds For Ophthalmic Use App 20160145192 - ALMIRANTE; Nicoletta ; et al. | 2016-05-26 |
| Nitric oxide donor compounds Grant 9,266,820 - Almirante , et al. February 23, 2 | 2016-02-23 |
| Quinone Based Nitric Oxide Donating Compounds For Ophthalmic Use App 20150283106 - Ongini; Ennio ; et al. | 2015-10-08 |
| Quinone based nitric oxide donating compounds Grant 9,079,821 - Ronsin , et al. July 14, 2 | 2015-07-14 |
| Quinone based nitric oxide donating compounds Grant 9,061,962 - Ronsin , et al. June 23, 2 | 2015-06-23 |
| Quinone Based Nitric Oxide Donating Compounds App 20140342998 - Ronsin; Gael ; et al. | 2014-11-20 |
| Nitric Oxide Donor Compounds App 20140288142 - ALMIRANTE; Nicoletta ; et al. | 2014-09-25 |
| Quinone Based Nitric Oxide Donating Compounds App 20140135389 - RONSIN; Gael ; et al. | 2014-05-15 |
| Angiotensin II receptor antagonists Grant 8,252,825 - Ali , et al. August 28, 2 | 2012-08-28 |
| Nitric oxide donor compounds Grant 8,003,811 - Almirante , et al. August 23, 2 | 2011-08-23 |
| Angiotensin II receptor antagonists Grant 7,880,014 - Sebhat , et al. February 1, 2 | 2011-02-01 |
| Angiotensin Ii Receptor Antagonists App 20100273845 - Ali; Amjad ; et al. | 2010-10-28 |
| Nitric Oxide Donor Compounds App 20100249189 - Almirante; Nicoletta ; et al. | 2010-09-30 |
| Angiotensin Ii Receptor Antagonists App 20100152259 - Sebhat; Iyassu K. ; et al. | 2010-06-17 |
| Nitric Oxide Donor Compounds App 20100099729 - Almirante; Nicoletta ; et al. | 2010-04-22 |
| Angiotensin II receptor antagonists App 20080194660 - Sebhat; Iyassu K. ; et al. | 2008-08-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 